07
Apr

Shares of Regulus spiked 10% Tuesday afternoon after its Big Pharma partner AstraZeneca stepped up to grab rights to a preclinical drug candidate for NASH with plans to steer it into clinical studies.

…read more

Source: Regulus surges after AstraZeneca snags rights to NASH drug

    

0 No comments